Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (China)

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd, also known as Panlong Pharmaceutical, was established in 1997. It is a modern high-tech enterprise with a core focus on the cultivation of medicinal herbs, pharmaceutical production, research and development, sales, and pharmaceutical logistics. The company entered the "Top 100 Enterprises in Shaanxi" in 2016 and was listed on the Shenzhen Stock Exchange in November 2017. It has been ranked among the top 100 pharmaceutical companies in China from 2018 to 2022. Panlong Pharmaceutical has five wholly-owned subsidiaries, including Shaanxi Panlong Pharmaceutical Co., Ltd., Shaanxi Shangluo Panlong Botanical Pharmaceutical Co., Ltd., Panlong Pharmaceutical Health Products Co., Ltd., Panlong Health Industry Holdings Co., Ltd., and Shaanxi Panlong Yunkang Network Technology Co., Ltd. It also has three holding companies, namely Shaanxi Qinmai Medical Preparation Concentration Co., Ltd., Shaanxi Qinling Qin Medicine Health Industry Co., Ltd., and Shaanxi Panlong Hongye Pharmacy Co., Ltd., as well as a comprehensive research service institution called Shaanxi Panlong Pharmaceutical Research Institute. The company's production base is located in the Panlong Ecological Industrial Park in Zhashui, at the southern foot of the Qinling Mountains, known as the "natural medicine treasure trove." Its management headquarters, pharmaceutical logistics, and pharmaceutical research and development distribution center are situated in the Modern Textile Industrial Park in Xi'an's Bahe New District. Panlong Pharmaceutical has 23 production lines, including tablets and capsules, which have obtained the new version of the National GMP certification. It also has supporting inspection and research equipment. With a strong product lineup consisting of over 100 specifications in 12 major functional categories, the company has achieved an annual production capacity of over 5 billion yuan. Its products are sold nationwide and highly trusted and praised by doctors, experts, and patients. Additionally, Panlong Pharmaceutical emphasizes cooperation and exchanges with higher education institutions and research institutions, collaborating on the development of new drugs and generic drugs, indicating a trend towards diversification. The company has been recognized as a "National Poverty Alleviation Leading Enterprise" by the National Poverty Alleviation Office and as an advanced private enterprise in the national "Ten Thousand Enterprises Assisting Ten Thousand Villages" program. It has been named a "National Contract-Honoring and Credit-Reliable Enterprise" by the State Administration for Industry and Commerce and has received various honors from the Shaanxi Provincial Party Committee and Government, such as "Excellent Private Enterprise in Shaanxi Province," "Advanced Collective in Shaanxi Province," "May 1st Labor Certificate," and "Excellent Private Enterprise." It has also been recognized by provincial-level departments as a "Shaanxi Province Integrity Enterprise," "Leading Agricultural Industrialization Enterprise in Shaanxi Province," "Innovative Enterprise in Shaanxi Province," "High-tech Enterprise," "Technology Demonstration Enterprise," "Model Taxpayer," "National Enterprise Technology Center," and "Advanced Collective in Shaanxi Province's Pharmaceutical Industry in the Fight against the COVID-19 Pandemic." The company has been included in the eighth batch of demonstration enterprises for cultivating industrial brands in Shaanxi Province, selected for the list of "Specialized, Refined, Unique, and New" small and medium-sized enterprises in Shaanxi Province in 2021, and has obtained approval from the Provincial Medical Institution Preparation Centralized Allocation Center. It has also been listed in the Top 100 Chinese Traditional Medicine Enterprises and recognized as one of the most promising listed companies in the pharmaceutical and health industry. As a rising force in the pharmaceutical industry, Shaanxi Panlong Pharmaceutical Group will continue to uphold its corporate mission of "establishing the Panlong brand and caring for human health." It adheres to the business philosophy of "people-oriented, quality first, steady operation, and long-term integrity." With the vision goal of "realizing the centennial dream of Panlong," the company aims to contribute to the development of traditional Chinese medicine and human health, creating a more splendid chapter.